BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Margonis GA, Gani F, Buettner S, Amini N, Sasaki K, Andreatos N, Ethun CG, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Krasnick B, Weber SM, Salem A, Martin RC, Scoggins C, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Maithel SK, Pawlik TM. Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium. HPB (Oxford) 2016;18:872-8. [PMID: 27527802 DOI: 10.1016/j.hpb.2016.05.016] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Laba P, Wang J, Zhang J. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma. BMC Cancer 2018;18:852. [PMID: 30153799 DOI: 10.1186/s12885-018-4747-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kamarajah SK, Al-Rawashdeh W, Parente A, Atherton P, Salti GI, Dahdaleh FS, Manas D, Hilal MA, White SA. Adjuvant chemotherapy for perihilar cholangiocarcinoma: A population-based comparative cohort study. Eur J Surg Oncol 2021:S0748-7983(21)00949-5. [PMID: 34916085 DOI: 10.1016/j.ejso.2021.12.002] [Reference Citation Analysis]
3 Ashai N, Prasad P, Rajdev L. Multimodality Management of Localized Biliary Cancer. Curr Treat Options in Oncol 2019;20. [DOI: 10.1007/s11864-019-0655-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bergquist JR, Shah HN, Habermann EB, Hernandez MC, Ivanics T, Kendrick ML, Smoot RL, Nagorney DM, Borad MJ, Mcwilliams RR, Truty MJ. Adjuvant systemic therapy after resection of node positive gallbladder cancer: Time for a well-designed trial? (Results of a US-national retrospective cohort study). International Journal of Surgery 2018;52:171-9. [DOI: 10.1016/j.ijsu.2018.02.052] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
5 Zhu X, Li T, Niu X, Chen L, Ge C. Identification of UBE2T as an independent prognostic biomarker for gallbladder cancer. Oncol Lett 2020;20:44. [PMID: 32802166 DOI: 10.3892/ol.2020.11903] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Ma Z, Dong F, Li Z, Zheng Z, Zhou Z, Zhuang H, Liu C, Huang B, Huang S, Zou Y, Yang L, Gong Y, Zhang C, Hou B. A Novel Prognostic Nomogram for Gallbladder Cancer after Surgical Resection: A Single-Center Experience. J Oncol 2021;2021:6619149. [PMID: 34447433 DOI: 10.1155/2021/6619149] [Reference Citation Analysis]
7 Kim TG. Patterns of initial failure after resection for gallbladder cancer: implications for adjuvant radiotherapy. Radiat Oncol J 2017;35:359-67. [PMID: 29249117 DOI: 10.3857/roj.2017.00388] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
8 Liu C, Rein L, Clarke C, Mogal H, Tsai S, Christians KK, Gamblin TC. Comparison of overall survival in gallbladder carcinoma at academic versus community cancer centers: An analysis of the National Cancer Data Base. J Surg Oncol 2020;122:176-82. [PMID: 32383268 DOI: 10.1002/jso.25907] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
9 Vega EA, Newhook TE, Kawaguchi Y, Qiao W, De Bellis M, Okuno M, Panettieri E, Nishino H, Duwe G, Piccino M, De Rose AM, Ruzzenente A, Uemoto S, Vivanco M, Chun YS, Cao HST, Tzeng CD, De Aretxabala X, Seo S, Giuliante F, Guglielmi A, Vinuela E, Vauthey JN. Conditional Recurrence-Free Survival after Oncologic Extended Resection for Gallbladder Cancer: An International Multicenter Analysis. Ann Surg Oncol 2021;28:2675-82. [PMID: 33666814 DOI: 10.1245/s10434-021-09626-3] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Tong Z, Qian J, Yang X, Jiangbo L. Artery-first vs vein-first surgical technique for segmentectomy of non-small cell lung cancer: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e22206. [PMID: 33031263 DOI: 10.1097/MD.0000000000022206] [Reference Citation Analysis]
11 Miyazaki M, Shimizu H, Yoshitomi H, Kato A, Furukawa K, Takayashiki T, Kuboki S, Takano S, Ohtsuka M. Clinical implication of surgical resection for recurrent biliary tract cancer: Does it work or not? Ann Gastroenterol Surg 2017;1:164-70. [PMID: 29863155 DOI: 10.1002/ags3.12036] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Okumura K, Gogna S, Gachabayov M, Felsenreich DM, McGuirk M, Rojas A, Quintero L, Seshadri R, Gu K, Dong XD. Gallbladder cancer: Historical treatment and new management options. World J Gastrointest Oncol 2021; 13(10): 1317-1335 [PMID: 34721769 DOI: 10.4251/wjgo.v13.i10.1317] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
13 Dominguez DA, Aversa JG, Hagerty BL, Diggs LP, Raoof M, Davis JL, Hernandez JM, Blakely AM. Prognostic impact of lymphovascular invasion in pT1-T3 gallbladder adenocarcinoma. J Surg Oncol 2020;122:1401-8. [PMID: 32783204 DOI: 10.1002/jso.26160] [Reference Citation Analysis]
14 Chen M, Li S, Topatana W, Lv X, Cao J, Hu J, Lin J, Juengpanich S, Shen J, Cai X. Development and Validation of a Nomogram for Predicting Survival in Gallbladder Cancer Patients With Recurrence After Surgery. Front Oncol 2020;10:537789. [PMID: 33505902 DOI: 10.3389/fonc.2020.537789] [Reference Citation Analysis]
15 Sun L, Hu W, Liu M, Chen Y, Jin B, Xu H, Du S, Xu Y, Zhao H, Lu X, Sang X, Zhong S, Yang H, Mao Y. High Systemic Inflammation Response Index (SIRI) Indicates Poor Outcome in Gallbladder Cancer Patients with Surgical Resection: A Single Institution Experience in China. Cancer Res Treat 2020;52:1199-210. [PMID: 32718144 DOI: 10.4143/crt.2020.303] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Kim BH, Chie EK, Kim K. ASO Author Reflections: Survival Benefit of Adjuvant Chemoradiotherapy for Gallbladder Cancer: The Role of Radiation Therapy Revisited. Ann Surg Oncol 2018;25:788-9. [PMID: 30324480 DOI: 10.1245/s10434-018-6894-7] [Reference Citation Analysis]
17 Gkika E, Hawkins MA, Grosu AL, Brunner TB. The Evolving Role of Radiation Therapy in the Treatment of Biliary Tract Cancer. Front Oncol 2020;10:604387. [PMID: 33381458 DOI: 10.3389/fonc.2020.604387] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Priya R, Jain V, Akhtar J, Chauhan G, Sakhuja P, Goyal S, Agarwal AK, Javed A, Jain AP, Polisetty RV, Sirdeshmukh R, Kar S, Gautam P. Plasma-derived candidate biomarkers for detection of gallbladder carcinoma. Sci Rep 2021;11:23554. [PMID: 34876625 DOI: 10.1038/s41598-021-02923-7] [Reference Citation Analysis]
19 Vega EA, Mellado S, Salehi O, Freeman R, Conrad C. Treatment of Resectable Gallbladder Cancer. Cancers 2022;14:1413. [DOI: 10.3390/cancers14061413] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Oven Ustaalioglu BB, Bilici A, Seker M, Kefeli U, Aydin D, Celik S, Demir T, Erkol B. Prognostic Factors for Operated Gallbladder Cancer. J Gastrointest Canc 2019;50:451-7. [DOI: 10.1007/s12029-018-0099-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Mathai AM, Alexander J, Huang HY, Li CF, Jeng YM, Fung KM, Harris WP, Swanson PE, Truong C, Yeh MM. S100P as a marker for poor survival and advanced stage in gallbladder carcinoma. Ann Diagn Pathol 2021;52:151736. [PMID: 33798925 DOI: 10.1016/j.anndiagpath.2021.151736] [Reference Citation Analysis]
22 Søreide K, Guest RV, Harrison EM, Kendall TJ, Garden OJ, Wigmore SJ. Systematic review of management of incidental gallbladder cancer after cholecystectomy. Br J Surg 2019;106:32-45. [PMID: 30582640 DOI: 10.1002/bjs.11035] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 12.0] [Reference Citation Analysis]
23 Sinnamon AJ, Wood AC, Satyadi MA, Levitt CV, Hardy O, Haider M, Kim RD, Anaya DA, Denbo JW. Anatomic patterns of recurrence in biliary tract cancers: does primary tumor site matter? J Gastrointest Oncol 2022;13:1413-22. [PMID: 35837169 DOI: 10.21037/jgo-21-868] [Reference Citation Analysis]
24 Kamarajah SK, Al-Rawashdeh W, White SA, Abu Hilal M, Salti GI, Dahdaleh FS. Adjuvant radiotherapy improves long-term survival after resection for gallbladder cancer A population-based cohort study. Eur J Surg Oncol 2021:S0748-7983(21)00724-1. [PMID: 34518052 DOI: 10.1016/j.ejso.2021.09.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Cotter G, Beal EW, Poultsides GA, Idrees K, Fields RC, Weber SM, Scoggins CR, Shen P, Wolfgang C, Maithel SK, Pawlik TM. Using machine learning to preoperatively stratify prognosis among patients with gallbladder cancer: a multi-institutional analysis. HPB 2022. [DOI: 10.1016/j.hpb.2022.06.008] [Reference Citation Analysis]
26 Chen C, Feng W, Zheng Y, Bao Y, Feng M. Intra-arterial chemotherapy improved survival of stage 2-3 gallbladder cancer after curative resection. Onco Targets Ther 2018;11:2975-9. [PMID: 29872309 DOI: 10.2147/OTT.S166246] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
27 Im JH, Lee WJ, Kang CM, Hwang HK, Seong J. Prognostic factors and patterns of loco-regional failure in patients with R0 resected gallbladder cancer. HPB (Oxford) 2020;22:1168-73. [PMID: 31784211 DOI: 10.1016/j.hpb.2019.10.2447] [Reference Citation Analysis]
28 Zaidi MY, Maithel SK. Updates on Gallbladder Cancer Management. Curr Oncol Rep. 2018;20:21. [PMID: 29500514 DOI: 10.1007/s11912-018-0664-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
29 Low SK, Giannis D, Thuong ND, Nam NH, Alshareef A, Koulas I, Geropoulos G, Moris D, Molmenti EP, Huy NT. Trends in Primary Gallbladder Cancer Incidence and Incidence-based Mortality in the United States, 1973 to 2015. Am J Clin Oncol 2022;45:306-15. [PMID: 35700074 DOI: 10.1097/COC.0000000000000918] [Reference Citation Analysis]
30 Karunaratne S, Gamage A, Bagwan IN. Descriptive analysis of incidental and operable gallbladder carcinoma cases: a UK centre experience. Pathologica 2022;114:138-45. [PMID: 35481564 DOI: 10.32074/1591-951X-291] [Reference Citation Analysis]
31 Wei S, Guo C, He J, Tan Q, Mei J, Yang Z, Liu C, Pu Q, Ma L, Yuan Y, Lin F, Zhu Y, Liao H, Wang W, Liu Z, Li Q, Jiang B, Li C, Xia L, Zhao K, Gan F, Cheng J, Wu Z, Wang Y, Lin Y, Kou Y, Che G, Chen L, Li J, Liu L. Effect of Vein-First vs Artery-First Surgical Technique on Circulating Tumor Cells and Survival in Patients With Non-Small Cell Lung Cancer: A Randomized Clinical Trial and Registry-Based Propensity Score Matching Analysis. JAMA Surg 2019;154:e190972. [PMID: 31042283 DOI: 10.1001/jamasurg.2019.0972] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 12.3] [Reference Citation Analysis]
32 Zhu J, Wu Y, Xiao W, Li Y. Survival Predictors of Resectable Gallbladder Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results Database. The American Surgeon. [DOI: 10.1177/00031348221074238] [Reference Citation Analysis]
33 Ganeshan D, Kambadakone A, Nikolaidis P, Subbiah V, Subbiah IM, Devine C. Current update on gallbladder carcinoma. Abdom Radiol (NY) 2021;46:2474-89. [PMID: 33386907 DOI: 10.1007/s00261-020-02871-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
34 Gao L, Shen Z, Xu H, Luo F, Zhang P, Chai T, Chen S, Kang M. Vein-first vs artery-first surgical technique for lobectomy of non-small cell lung cancer: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e20768. [PMID: 32590754 DOI: 10.1097/MD.0000000000020768] [Reference Citation Analysis]